About us
Who we are
The Leadership Team
What we do
Overview
Lentiviral Vector Manufacturing
Retroviral Vector Manufacturing
Adeno-Associated Viral Vector Manufacturing
Quality Control Testing Services
Viral Vector Process Development
News
Contact us
News & Features
24th April, 2026
Supporting the KHP Advanced Therapies Conference 2026
21st January, 2026
Expansion of Manufacturing Capability with scale-X™ carbo Bioreactor
10th December, 2025
GTVF provides viral vector for clinical trial on aggressive and incurable blood cancer
